FILTER
FILTERED INTERVIEW RESULTS
Sergio Marcondes & Emilio Nager
GENERAL MANAGER & COMMERCIAL MANAGER INTERNATIONAL MARKETS, BRASKEM
“Some countries are more advanced than others when it comes to understanding the product and implementing sustainability policies. Indeed, there is not a single answer to this problem. Banning single-use plastics is one thing, but the problem is not the product – it is how you deal with it at the end of the life cycle, which applies not just to plastic, but also to any high volume product.”
Ricardo Diogo
DIRECTOR BUSINESS DEVELOPMENT, OILTANKING
A look at the liquids storage market in Latin America and its potential consolidation.
Matthias Vorbeck & Alejandro Gabrielli
GENERAL MANAGER & REGIONAL MANAGER, ANASTACIO OVERSEAS
The company continues expanding in Latin America capitalizing the synergies with the distribution business of Química Anastacio.
Bob Patel
CEO, LYONDELLBASELL
LyondellBasell explains why the company is eager to expand on a grand scale into Latin America.
Fernando Figueiredo
CEO, ABIQUIM
Abiquim explains to GBR how Brazil can reverse the ailing fortunes of its petrochemical industry.
Richard Pino
VICE PRESIDENT SALES AND MARKETING, LATIN AMERICA, CRODA DO BRASIL
Recent acquisitions and investments have considerably enlarged Croda's presence in Brazil both in manufacturing and in R&D with its new innovation center at Campinas.
Ricardo Diogo
DIRECTOR BUSINESS DEVELOPMENT, OILTANKING MEXICO
Oiltanking plans to operate two terminals in Tuxpan on the Gulf Coast that will import fuels within 18 months.
Érica Takeda
MANAGING DIRECTOR, BRENNTAG
Brenntag in Brazil is determined to continue its expansion through acquisitions.
Reinaldo Kröger & Edson de Paiva
PRESIDENT & OPERATIONS DIRECTOR, UNIGEL
Unigel is Latin America’s leading producer of acrylics and styrenics.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
